Royalty Pharma has a total of 211 patents globally, out of which 135 have been granted. Of these 211 patents, more than 36% patents are active. Thailand is where Royalty Pharma has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Royalty Pharma.
Royalty Pharma was founded in the year 1996. The Company acquires biopharmaceutical royalties. The Company funds innovation directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties and indirectly when it acquires existing royalties from the original innovators. As of April 2023, the market cap of Royalty Pharma is $16.2 Billion.
Do read about some of the most popular patents of Royalty Pharma which have been covered by us in this article and also you can find Royalty Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Royalty Pharma patent portfolio.
How many patents does the founder and the CEO of Royalty Pharma have?
The founder and CEO Pablo Legoretta has 0 patent.
How many patents does Royalty Pharma have?
Royalty Pharma has a total of 211 patents globally. These patents belong to 49 unique patent families. Out of 211 patents, 76 patents are active.
How Many Patents did Royalty Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Royalty Pharma Applications Filed | Royalty Pharma Patents Granted |
| 2022 | – | 2 |
| 2021 | – | 6 |
| 2020 | 1 | 7 |
| 2019 | 2 | 6 |
| 2018 | 1 | 3 |
| 2017 | 2 | 13 |
| 2016 | 3 | 14 |
| 2015 | 3 | 12 |
| 2014 | 13 | 16 |
| 2013 | 14 | 18 |
| 2012 | 4 | 6 |
| 2011 | 16 | 6 |
How many Royalty Pharma patents are Alive/Dead?
How Many Patents did Royalty Pharma File in Different Countries?
Countries in which Royalty Pharma Filed Patents
| Country | Patents |
| Thailand | 20 |
| Europe | 16 |
| Japan | 15 |
| Hong Kong (S.A.R.) | 14 |
| United States Of America | 14 |
| Denmark | 11 |
| Spain | 9 |
| Slovenia | 8 |
| Germany | 7 |
| Croatia | 7 |
| Portugal | 6 |
| Cyprus | 6 |
| Canada | 5 |
| Brazil | 5 |
| Lithuania | 5 |
| Korea (South) | 5 |
| Luxembourg | 5 |
| Australia | 4 |
| Mexico | 4 |
| Israel | 4 |
| Viet Nam | 4 |
| Indonesia | 4 |
| Singapore | 3 |
| Chile | 3 |
| Gulf Cooperation Council | 3 |
| Poland | 3 |
| China | 2 |
| New Zealand | 2 |
| Albania | 2 |
| Norway | 2 |
| South Africa | 2 |
| Taiwan | 1 |
| Hungary | 1 |
| Brunei | 1 |
| Eurasia | 1 |
| Turkey | 1 |
| Russia | 1 |
| Argentina | 1 |
| Finland | 1 |
| Serbia | 1 |
| India | 1 |
| Czech Republic | 1 |
Where are Research Centres of Royalty Pharma Patents Located?
10 Best Royalty Pharma Patents
US20040209915A1 is the most popular patent in the Royalty Pharma portfolio. It has received 169 citations so far from companies like Theravance, Glaxo Group Limited and Zentiva.
Below is the list of 10 most cited patents of Royalty Pharma:
| Publication Number | Citation Count |
| US20040209915A1 | 169 |
| US20040209860A1 | 164 |
| US7109205B2 | 43 |
| US6559338B1 | 33 |
| US6677465B2 | 15 |
| US7119097B2 | 13 |
| US20100216800A1 | 2 |
| JP4787184B2 | 2 |
| JP4512105B2 | 2 |
| JP4512106B2 | 2 |